Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P
Gastroenterology Unit, Maggiore Hospital, Bologna, Italy.
Gut. 1993 Oct;34(10):1364-9. doi: 10.1136/gut.34.10.1364.
Scintigraphy with autologous granulocytes labelled by technetium-99m hexamethyl, propylene amine oxime (99mTc-HMPAO) was performed in 103 Crohn's disease patients and 52 healthy controls. In 31 patients endoscopic and histologic activity was compared with scan activity index. In the 98 patients with a positive scan, the extent of Crohn's disease, assessed by scintigraphy, was compared with that evaluated by small bowel x ray or colonoscopy with biopsies. In 48 patients, Crohn's disease activity index, activity index, simple index, erythrocyte sedimentation rate, C-reactive protein were correlated with the scan results. In 16 patients the five parameters and scan were repeated after treatment with methyl-prednisolone (10 cases), enteral nutrition (3), and 5-acetylsalicylic acid (3). The results showed that 99mTc-HMPAO granulocyte scan had a 95% sensitivity and 100% specificity to detect active inflammation; it correctly showed an abscess or a fistula in all the 24 cases found. The correlation between histological inflammatory activity and scan activity index was highly significant (r = 0.85; p < 0.01), less significant (r = 0.65; p < 0.01) between endoscopy and scan activity index. The evaluation for the extent of Crohn's disease by scan was completely correct in the small bowel (100%) and 93% correct in the large bowel. No correlation was seen between the three clinical activity parameters and scanning; in more than 80% of the cases in remission on the basis of a clinical or laboratory index, scintigraphy remained positive. Medical treatment was effective on the clinical indices but not on the active inflammation in the ileum, whereas it led to a negative scan in 5/11 cases in the large intestine. Scintigraphy with 99mTc-HMPAO granulocyte plays an important part in Crohn's disease for the diagnosis of complications, for activity and assessment of the extent, and for the treatment results evaluation.
对103例克罗恩病患者和52例健康对照者进行了用锝-99m六甲基丙烯胺肟(99mTc-HMPAO)标记的自体粒细胞闪烁扫描。在31例患者中,将内镜和组织学活动与扫描活动指数进行了比较。在98例扫描阳性的患者中,将通过闪烁扫描评估的克罗恩病范围与通过小肠X线或结肠镜活检评估的范围进行了比较。在48例患者中,将克罗恩病活动指数、活动指数、简易指数、红细胞沉降率、C反应蛋白与扫描结果进行了相关性分析。在16例患者中,在用甲基泼尼松龙(10例)、肠内营养(3例)和5-乙酰水杨酸(3例)治疗后,重复测定了这五个参数和扫描结果。结果显示,99mTc-HMPAO粒细胞扫描检测活动性炎症的敏感性为95%,特异性为100%;在发现的所有24例病例中,均正确显示了脓肿或瘘管。组织学炎症活动与扫描活动指数之间的相关性非常显著(r = 0.85;p < 0.01),内镜与扫描活动指数之间的相关性较弱(r = 0.65;p < 0.01)。通过扫描对克罗恩病范围的评估在小肠中完全正确(100%),在大肠中正确度为93%。三个临床活动参数与扫描之间未发现相关性;在超过80%根据临床或实验室指标处于缓解期的病例中,闪烁扫描仍为阳性。药物治疗对临床指标有效,但对回肠的活动性炎症无效,而在大肠中,11例中有5例药物治疗后扫描转为阴性。用99mTc-HMPAO粒细胞进行闪烁扫描在克罗恩病的并发症诊断、活动度和范围评估以及治疗效果评价中发挥着重要作用。